ClinicalTrials.gg

Fusion Pharmaceuticals Inc. clinical trials

Acquired by AstraZeneca, Jun 4, 2024 · source ↗

The registry lists 5 studies whose lead sponsor is Fusion Pharmaceuticals Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 6, 2026.

Before and after it joined AstraZeneca

First submitted before Fusion Pharmaceuticals Inc. became part of AstraZeneca
4
First submitted after Fusion Pharmaceuticals Inc. became part of AstraZeneca
1
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Fusion Pharmaceuticals Inc.’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

2 of Fusion Pharmaceuticals Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 5 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Under way, not recruiting360%
  • Stopped early240%

Phase

  • Phase 24
  • Phase 12

Where

  • United States4
  • Australia3
  • Canada1

Over the years

  1. 119
  2. 20
  3. 21
  4. 22
  5. 23
  6. 24
  7. 25
  8. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Fusion Pharmaceuticals Inc.5 studies

Something wrong with this grouping? Tell us on the AstraZeneca page.

Studies

Recruiting first, then most recently updated. Showing 5 of 5. All AstraZeneca studies →